and we studied the case in this patient regarding both the pathological fi ndings and the phenotypic expression of mucins. Furthermore, we performed a literature search on gastric cancers associated with CCS, to elucidate the clinicopathological features of such gastric cancers associated with CCS.
A 59-year-old Japanese man had been treated for membranous glomerulonephritis (MGN) over the past 30 years. There was no family history of GI polyposis. He had been exhibiting onychodystrophy, hyperpigmentation, and hypogeusia. Gastroscopy, performed because of anemia, revealed numerous polypoidal lesions of various sizes with edematous mucosa throughout the stomach (Fig. 1A) . Pathologically, adenocarcinoma cells were detected in the largest polypoidal lesion and an endoscopic examination of the lower GI tract showed a number of scattered small polyps in the colorectum. An upper and lower GI series revealed multiple fi lling defects throughout the stomach, duodenum, small intestine, and colorectum; thus, he was diagnosed with CCS complicated with gastric cancer. The results of laboratory examinations revealed anemia, hypoproteinemia (total serum protein, 3.6 g/dl; albumin, 1.8 g/dl), renal dysfunction (blood urea nitrogen, 58 mg/dl, creatinine, 4.1 mg/dl), electrolyte abnormality, and low mineral (Ca, Zn) values. The polyps in the small intestine and colon were small, and he did not have severe GI symptoms; a total gastrectomy was performed with a Rouxen-Y reconstruction. The surgical specimen revealed a giant tumor measuring 92 × 72 mm in size, with a number of polyps throughout the whole stomach (Fig. 1B) . Histologically, the surface of the giant tumor consisted of well-differentiated and moderately differentiated tubular adenocarcinoma which showed a cribriform pattern ( Fig. 2A) . The cancerous epithelia had spread
Introduction
Cronkhite-Canada syndrome (CCS) is a rare nonhereditary disorder with generalized gastrointestinal polyposis, associated with ectodermal changes such as alopecia, onychodystrophy, and hyperpigmentation [1] . Although previous reports have noted that this syndrome was rarely associated with malignancy [2] , recently some reports have noted the association of CCS with carcinomas in the gastrointestinal (GI) tract [3, 4] . This report documents a Japanese man with CCS who underwent a total gastrectomy for gastric tumors, superfi cially within the mucosal layer, covering almost the whole surface of the tumor; dysplasia was rarely found. There was no fi nding of lymph node metastasis or distant metastasis; therefore, the histological stage of the gastric cancer was stage IA (T1N0M0) according to the Japanese classifi cation of gastric carcinoma (2nd English edition) (website: http://www.jgca.jp/gakkai/ foreigner.html). The histological structure of the welldifferentiated adenocarcinoma (Fig. 2B) resembled that of hyperplasia, with edematous stroma, cystic dilatation of the glands, and infi ltration of infl ammatory cells, features that are characteristic of CCS polyps (Fig. 2C) . The identity of the pathological fi ndings with those of CCS polyps led us to suppose that the carcinoma had arisen from hyperplastic CCS polyps.
Our notion on the pathological fi ndings and the report by Kushima et al. [5] , which referred to "adenocarcinoma arising from hyperplastic polyps," urged us to study the phenotypic expression of the mucins in the gastric cancer tissue. This study revealed that MUC5AC was strongly positive, but MUC2 and MUC6 were negative (Fig. 3) . The results supported the diagnosis of the tumor as a gastric-type well-differentiated adenocarcinoma; the concept of such tumors has recently become accepted [5] . In addition, pathology examination detected Helicobacter pylori infection. The patient showed marked alleviation of his hypoproteinemia (total serum protein, 6.1 g/dl; albumin, 3.3 g/dl) and was discharged subsequently without any complications.
Discussion
CCS was fi rst reported in 1955 as generalized GI polyposis with ectodermal changes, including alopecia, hyperpigmentation, and onychodystrophy [1] . Since that time CCS has been reported mostly in Japan. Goto [6] reviewed 154 CCS cases before 1985 and reported that 110 of the patients (71.4%) were Japanese. The clinical manifestations of CCS include not only GI symptoms such as diarrhea, anorexia, weight loss, abdominal pain, and vomiting, but also ectodermal changes such as hypogeusia, onychodystrophy, hair loss, and hyperpigmentation [7] . Hypoproteinemia caused by protein loss and malabsorption have been observed frequently; furthermore, electrolyte and mineral abnormalities may be manifested. The present patient showed symptoms of onychodystrophy, hyperpigmentation, severe hypoproteinemia, electrolyte abnormality, and low mineral (Ca, Zn) values. Because he had been treated for MGN, the hypoproteinemia before the surgical resection was therefore not thought to have been caused by CCS alone. On the other hand, Sagara et al. [8] reported a CCS patient who completely recovered from hypoproteinemia after a gastrectomy; also, in the present patient, the hypoproteinemia was markedly alleviated after the total gastrectomy. This suggested that the protein had been mainly lost from the stomach in both these patients.
In our patient, the histological structure of welldifferentiated adenocarcinoma in the tumor (Fig. 2B) resembled that of hyperplasia in other CCS polyps (Fig. 2C) , which led us to suppose that the carcinoma had arisen from the hyperplastic CCS polyps. Kushima et al. [5] documented that 11 (78.6%) of 14 differentiated-type carcinomas in hyperplastic polyps were gastric-type adenocarcinomas. Recently, the concept of gastric-type well-differentiated adenocarcinoma, a disease entity which is different from "intestinal-type" and which arises in nonintestinalized gastric mucosa, has been established following the discovery of MUC genes coding core proteins of mucin, although differentiated adenocarcinomas of the stomach have been commonly thought to arise from intestinal metaplasia [5] . These results urged us to study the phenotypic expression of mucins in the gastric cancer tissue. In our patient, MUC5AC, which is expressed in the superfi cial foveolar epithelia, was positive, and MUC2, which is expressed in intestinal metaplasia, was negative (Fig. 3) . These results suggested that this cancer could be classifi ed as gastric-type, not intestinal-type, welldifferentiated adenocarcinoma.
CCS has rarely been reported to be associated with carcinomas [2] ; however, recently, the development of cancer of the stomach in CCS patients has been reported in some articles. Egawa et al. [3] reported an association rate between CCS and gastric cancer of 5.1% (19/374 cases) and suggested that CCS was a high-risk condition for stomach malignancy. Until now, 32 CCS cases associated with gastric cancers have been reported in the literature, and all of these cases were in Japanese patients (Table 1) [3, 8, 9, 10] . One important reason that gastric carcinoma has been described solely in Japanese patients with CCS could be because of the health care surveillance system in Japan, especially regarding the progress of mass screening and regular check-ups with endoscopic examinations. Another possible reason may be the spread of Helicobacter pylori infection. Recently, the association of H. pylori infection, especially cytotoxin-associated gene A (CagA)-positive H. pylori strain infection, with the development of stomach cancer, has been actively discussed [11] ; furthermore, a high incidence of gastric cancer is mostly seen in those regions where east Asian type CagApositive H. pylori is predominant, such as in Japan [12] . It is therefore possible that H. pylori infection is associated with the development of gastric cancer in CCS patients. Because there have been no reports documenting H. pylori infection in CCS patients, except for our patient, it is diffi cult to discuss whether H. pylori infection is associated with the development of stomach cancer in CCS patients. This subject should be the next goal to be clarifi ed.
As summarized in Table 1 , in gastric cancers that developed in CCS patients, the depth of cancer invasion was limited to within the submucosa in spite of their large sizes, and they were frequently well-differentiated histological types. The invasion in our present patient was limited to within the mucosal layer in spite of its huge size as well. Considering these results, gastric cancers associated with CCS may demonstrate a low grade of malignancy. A literature search was carried out to analyze gastric cancers in 32 Japanese CCS patients, and their clinicopathological features were compared with those of 12 533 gastric cancers treated at the Cancer Institute Hospital (Tokyo, Japan) from 1946 to 2004 [13] . This revealed that the gastric cancers in CCS patients were mostly limited to within the submucosa (T1; 24 of 36 lesions; 66.6%) in spite of their large sizes. On the other hand, 4514 lesions (36.0%) from the Cancer Institute Hospital were within T1. In a study focusing on gastric cancer cases with available information on both their tumor depth and diameter, the average diameter of T1 gastric cancer in CCS was 47.5 mm, which was much greater than that in the common gastric cancers observed at the Cancer Institute Hospital (33.0 mm). These results may support the notion that the steps of carcinogenesis in CCS are different from those in common gastric cancers.
In clinical follow up, it is important to remember the clinicopathological features of CCS tumors, including the fi ndings that CCS tumors are associated with malig- 
